INSMED Inc
INSMReported to SECin USCIK 0001104506Filings at SEC EDGAR
No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.
This page is free to read, and it stops after 5 rows. Those are the 5 most recent Form 4 lines at this company, out of 34. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.
The most recent filings
Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.
| Filed by | Type | Value | Reported | Filed by | Value | Type | Shares | Reported |
|---|---|---|---|---|---|---|---|---|
| Brennan David R— | Open-market sell | $3,100,00025,000 shares | Sep 11, 2026 | Brennan David R | $3,100,000 | Open-market sell | 25,000 | Sep 11, 2026 |
| SHAROKY MELVIN MD— | Open-market sell | $637,6505,000 shares | Aug 19, 2026 | SHAROKY MELVIN MD | $637,650 | Open-market sell | 5,000 | Aug 19, 2026 |
| Adsett RogerChief Operating Officer | Option exercise | nothing paid80,970 shares | Aug 12, 2026 | Adsett RogerChief Operating Officer | nothing paid | Option exercise | 80,970 | Aug 12, 2026 |
| Adsett RogerChief Operating Officer | Option exercise | nothing paid76,600 shares | Aug 12, 2026 | Adsett RogerChief Operating Officer | nothing paid | Option exercise | 76,600 | Aug 12, 2026 |
| Adsett RogerChief Operating Officer | Option exercise | nothing paid82,280 shares | Aug 12, 2026 | Adsett RogerChief Operating Officer | nothing paid | Option exercise | 82,280 | Aug 12, 2026 |
Lobbying
From the quarterly LD-2 filings at the U.S. Senate — a different register, and a different kind of fact.
This is not a trade and it is not scored. A lobbying filing says who lobbied for whom, on which issues, and for how much — it says nothing about the share price and nothing about this company’s insiders. The link between the client names in that register and INSMED Inc is a reviewed rule of ours: an LD-2 names a client and carries no ticker, no CIK and no LEI.